GS
EW icon

George Soros’s Edwards Lifesciences EW Stock Holding History

George Soros’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-250,000
Closed -$18.5M – 228
2024
Q4 		$18.5M Sell
250,000
-50,000
-17% -$3.5M 0.28% 93
2024
Q3 		$19.8M Buy
+300,000
New +$21.8M 0.29% 79
2024
Q2 		– Sell
-75,000
Closed -$7.17M – 190
2024
Q1 		$7.17M Buy
+75,000
New +$6.3M 0.12% 130
2017
Q3 		– Sell
-13,800
Closed -$544K – 243
2017
Q2 		$544K Buy
+13,800
New +$504K 0.01% 127

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

George Soros's EW Position: Q1 2025 in Review

George Soros sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 250,000 shares — an estimated $18.5M sold.

George Soros first reported a position in EW in Q2 2017 and held it in 4 quarters. The position peaked at $19.8M in Q3 2024. 1,205 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • George Soros reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • George Soros sold 250,000 Edwards Lifesciences shares in Q1 2025, an estimated $18.5M.
  • George Soros first reported a position in Edwards Lifesciences in Q2 2017 and held it in 4 quarters.
  • George Soros's Edwards Lifesciences position peaked at $19.8M in Q3 2024.
  • 1,205 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Soros Fund Management's 13F filing for Q1 2025, filed 15 May 2025.